Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains

Kazuhiko Hayashi, Yoshiaki Katano, Masatoshi Ishigami, Akihiro Itoh, Yoshiki Hirooka, Isao Nakano, Kentaro Yoshioka, Motoyoshi Yano, Hidenori Toyoda, Takashi Kumada, Hidemi Goto

研究成果: Article

17 引用 (Scopus)

抜粋

Background and Aims: Acute hepatitis caused by lamivudine (LMV)-resistant strains has not been reported, and the clinical impact of LMV-resistant strains on acute hepatitis is not known. The aim of this study was to investigate the molecular and clinical characteristics of patients with acute hepatitis B caused by LMV-resistant strains. Methods: Forty-five patients with acute hepatitis B were studied. Hepatitis B virus (HBV) subgenotypes and LMV-resistance mutations were determined by direct sequencing of the preS and polymerase regions, respectively. Results: HBV subgenotypes A2 (n = 18), B1 (n = 1), B2 (n = 3), B3 (n = 2), C1 (n = 1), C2 (n = 19) and C6 (n = 1) were detected in patients with acute hepatitis. LMV-resistance mutations were detected in two patients. LMV-resistance mutations (L180M, M204I) were detected in a patient with subgenotype C2 who had acute self-limited hepatitis. The other patient with LMV-resistance mutations (L180M, M204V) was infected with subgenotype A2 and had severe hepatitis. Conclusion: LMV-resistant strains are rare, but they are starting to be found in patients with acute hepatitis B. Surveillance for detecting drug-resistant HBV strains would be important for clinical practice.

元の言語English
ページ(範囲)745-749
ページ数5
ジャーナルJournal of Gastroenterology and Hepatology (Australia)
25
発行部数4
DOI
出版物ステータスPublished - 04-2010

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

フィンガープリント Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用